Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma

Adam F. Stewart, M. Eric Brewer, Brian Daley, Frederick A. Klein, Edward Kim

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background:: The short-term efficacy and safety of percutaneous embolization for the treatment of hemodynamically unstable patients with grade 5 renal injuries secondary to blunt trauma has been previously established; however, there has been no published intermediate-term follow-up. The purpose of this study is to report intermediate-term follow-up and complications for this treatment modality. Methods:: A retrospective study was performed to determine intermediate-term outcomes in an observational cohort of patients who underwent percutaneous embolization for the management of grade 5 blunt renal trauma. Demographic and perioperative data were obtained. Follow-up was performed via mail and/or phone questionnaires. Results:: Between October 2004 and July 2008, 10 hemodynamically unstable patients with grade 5 blunt renal trauma were treated with percutaneous embolization. Mean age of the cohort was 29 years (range, 5-50). Mean follow-up via phone and/or mail questionnaires was 2.7 years (1.5-5.1 years). One patient reported a new diagnosis of hypertension, which is well controlled by a single antihypertensive medication. There were no reported complications of refractory hypertension, altered renal function, new urolithiasis, chronic pain, urine leak, arteriovenous fistula, or pseudoaneurysm. No other procedures were required after the initial embolization for their renal trauma. Conclusions:: Management of grade 5 renal injuries with percutaneous embolization is safe and is not associated with intermediate-term adverse events.

Original languageEnglish (US)
Pages (from-to)468-470
Number of pages3
JournalJournal of Trauma - Injury, Infection and Critical Care
Volume69
Issue number2
DOIs
StatePublished - Jan 1 2010

Fingerprint

Kidney
Wounds and Injuries
Postal Service
Renal Hypertension
Urolithiasis
False Aneurysm
Arteriovenous Fistula
Chronic Pain
Antihypertensive Agents
Retrospective Studies
Demography
Urine
Hypertension
Safety
Therapeutics
Surveys and Questionnaires

All Science Journal Classification (ASJC) codes

  • Surgery
  • Critical Care and Intensive Care Medicine

Cite this

Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma. / Stewart, Adam F.; Brewer, M. Eric; Daley, Brian; Klein, Frederick A.; Kim, Edward.

In: Journal of Trauma - Injury, Infection and Critical Care, Vol. 69, No. 2, 01.01.2010, p. 468-470.

Research output: Contribution to journalArticle

@article{0cc8803a79bc4fb791035c499cd78df4,
title = "Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma",
abstract = "Background:: The short-term efficacy and safety of percutaneous embolization for the treatment of hemodynamically unstable patients with grade 5 renal injuries secondary to blunt trauma has been previously established; however, there has been no published intermediate-term follow-up. The purpose of this study is to report intermediate-term follow-up and complications for this treatment modality. Methods:: A retrospective study was performed to determine intermediate-term outcomes in an observational cohort of patients who underwent percutaneous embolization for the management of grade 5 blunt renal trauma. Demographic and perioperative data were obtained. Follow-up was performed via mail and/or phone questionnaires. Results:: Between October 2004 and July 2008, 10 hemodynamically unstable patients with grade 5 blunt renal trauma were treated with percutaneous embolization. Mean age of the cohort was 29 years (range, 5-50). Mean follow-up via phone and/or mail questionnaires was 2.7 years (1.5-5.1 years). One patient reported a new diagnosis of hypertension, which is well controlled by a single antihypertensive medication. There were no reported complications of refractory hypertension, altered renal function, new urolithiasis, chronic pain, urine leak, arteriovenous fistula, or pseudoaneurysm. No other procedures were required after the initial embolization for their renal trauma. Conclusions:: Management of grade 5 renal injuries with percutaneous embolization is safe and is not associated with intermediate-term adverse events.",
author = "Stewart, {Adam F.} and Brewer, {M. Eric} and Brian Daley and Klein, {Frederick A.} and Edward Kim",
year = "2010",
month = "1",
day = "1",
doi = "10.1097/TA.0b013e3181e5407a",
language = "English (US)",
volume = "69",
pages = "468--470",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma

AU - Stewart, Adam F.

AU - Brewer, M. Eric

AU - Daley, Brian

AU - Klein, Frederick A.

AU - Kim, Edward

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background:: The short-term efficacy and safety of percutaneous embolization for the treatment of hemodynamically unstable patients with grade 5 renal injuries secondary to blunt trauma has been previously established; however, there has been no published intermediate-term follow-up. The purpose of this study is to report intermediate-term follow-up and complications for this treatment modality. Methods:: A retrospective study was performed to determine intermediate-term outcomes in an observational cohort of patients who underwent percutaneous embolization for the management of grade 5 blunt renal trauma. Demographic and perioperative data were obtained. Follow-up was performed via mail and/or phone questionnaires. Results:: Between October 2004 and July 2008, 10 hemodynamically unstable patients with grade 5 blunt renal trauma were treated with percutaneous embolization. Mean age of the cohort was 29 years (range, 5-50). Mean follow-up via phone and/or mail questionnaires was 2.7 years (1.5-5.1 years). One patient reported a new diagnosis of hypertension, which is well controlled by a single antihypertensive medication. There were no reported complications of refractory hypertension, altered renal function, new urolithiasis, chronic pain, urine leak, arteriovenous fistula, or pseudoaneurysm. No other procedures were required after the initial embolization for their renal trauma. Conclusions:: Management of grade 5 renal injuries with percutaneous embolization is safe and is not associated with intermediate-term adverse events.

AB - Background:: The short-term efficacy and safety of percutaneous embolization for the treatment of hemodynamically unstable patients with grade 5 renal injuries secondary to blunt trauma has been previously established; however, there has been no published intermediate-term follow-up. The purpose of this study is to report intermediate-term follow-up and complications for this treatment modality. Methods:: A retrospective study was performed to determine intermediate-term outcomes in an observational cohort of patients who underwent percutaneous embolization for the management of grade 5 blunt renal trauma. Demographic and perioperative data were obtained. Follow-up was performed via mail and/or phone questionnaires. Results:: Between October 2004 and July 2008, 10 hemodynamically unstable patients with grade 5 blunt renal trauma were treated with percutaneous embolization. Mean age of the cohort was 29 years (range, 5-50). Mean follow-up via phone and/or mail questionnaires was 2.7 years (1.5-5.1 years). One patient reported a new diagnosis of hypertension, which is well controlled by a single antihypertensive medication. There were no reported complications of refractory hypertension, altered renal function, new urolithiasis, chronic pain, urine leak, arteriovenous fistula, or pseudoaneurysm. No other procedures were required after the initial embolization for their renal trauma. Conclusions:: Management of grade 5 renal injuries with percutaneous embolization is safe and is not associated with intermediate-term adverse events.

UR - http://www.scopus.com/inward/record.url?scp=77955917247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955917247&partnerID=8YFLogxK

U2 - 10.1097/TA.0b013e3181e5407a

DO - 10.1097/TA.0b013e3181e5407a

M3 - Article

VL - 69

SP - 468

EP - 470

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 2

ER -